TOKYO -- The fate of roughly 120 million doses of AstraZeneca's COVID-19 vaccine remains up in the air in Japan after the government paused the rollout the very same day it gave the green light for emergency use.
COVID vaccines
120m AstraZeneca shots caught in Japan's regulatory limbo
Two-step authorization stalls rollout as production begins
.jpg?width=780&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto)
Vials of the coronavirus vaccine developed by Oxford University and AstraZeneca: The fate of Japan's 120 million doses of the vaccine remains up in the air. © Reuters
Read Next
Latest on COVID vaccines
